Public filings / KLRA on Yahoo Finance (opens in a new tab)
KLRA: insider buying, 13F holders, analyst moves
Kailera Therapeutics Inc - US
A summary of public filings about Kailera Therapeutics Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold KLRA
Combined reported value $278.6M.
Holders among our 100 managers: 0 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| RTW Investments | $237.4M | 2.03% | New |
| Farallon Capital | $24.2M | 0.14% | New |
| Deep Track Capital | $15.4M | 0.23% | New |
| Tudor Investment | $1.1M | 0.00% | New |
| Soros Fund Management | $441K | 0.01% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.